According to FutureWise analysis the market for Seasonal Influenza Vaccines Therapeutics in 2023 is US$ 8.59 billion, and is expected to reach US$ 17.39 billion by 2031 at a CAGR of 9.20%.
Flu season is the period of the year when seasonal influenza viruses cause upper and lower respiratory tract infections. Most cases of seasonal influenza are transmitted either directly to the patient or indirectly. Influenza vaccination, also known as flu injection, provides protection against influenza viruses.
The influenza vaccine consists of three kinds of weakened viruses, namely influenza type A with H3N2 strain, influenza type A with H1N1 strain, and influenza type B strain. Influenza viruses can be classified into three types A, B and C, where types A, B,
C cause seasonal flu as well as respiratory illnesses.
Influenza is a viral infection of the respiratory system caused by the flu virus. The influenza virus spreads through respiratory droplets and is contagious. In addition, it can spread through physical contact or while talking. Influenza viruses circulate continuously, causing regional epidemics and outbreaks, resulting in thousands of deaths. A change in the influenza virus strain is resulting in an annual change in the vaccine strain. The Centers for Disease Control and Prevention (CDC) have recommended baloxavir marboxil (Xofluza) for the treatment of influenza symptoms have recommended certain influenza vaccines such as baloxavir marboxil (Xofluza) to treat the symptoms in patients. Influenza vaccines typically contain three influenza strains including influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Seasonal Influenza Vaccines Therapeutics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Seasonal Influenza Vaccines Therapeutics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.